Nosebleed

The nasal cavity is a highly vascularized area, crucial for its role in conditioning inhaled air. The rich blood supply originates from branches of both the internal and external carotid arteries. The anterior portion, particularly Kiesselbach's plexus (Little's area), is a convergence of several vessels (anterior ethmoidal artery, sphenopalatine artery, greater palatine artery, and superior labial artery) and is the source of approximately 90% of anterior nosebleeds.

These are typically superficial and easier to control. Posterior nosebleeds, though less frequent, originate from deeper vessels like the sphenopalatine artery or Woodruff's plexus and are often more severe, presenting a greater challenge in hemostasis due to their location and higher blood flow.

The causes of epistaxis are diverse, ranging from local trauma to systemic conditions. Digital trauma (nose picking) is a leading cause in children and adolescents. Environmental factors like dry air, particularly in heated indoor environments or arid climates, can lead to mucosal drying, cracking, and subsequent bleeding. Inflammatory conditions such as allergic rhinitis or sinusitis can compromise the nasal mucosa.

Systemic factors include hypertension, which can exacerbate bleeding, and coagulopathies, whether inherited (e.g., hemophilia) or acquired (e.g., liver disease, vitamin K deficiency). Medications are significant contributors; anticoagulants (warfarin, heparin, DOACs) and antiplatelet agents (aspirin, clopidogrel) directly impair hemostasis. Inhaled corticosteroids, while beneficial for nasal inflammation, can cause local mucosal thinning and dryness, increasing bleeding risk if not used properly.

Diagnosis of epistaxis is primarily clinical, based on patient history and direct visualization of the bleeding source, if possible. For anterior bleeds, direct pressure applied to the soft part of the nose for a sustained period (at least 5-10 minutes) is the initial management. If conservative measures fail, anterior nasal packing with materials like gauze, merocel, or nasal balloons may be employed.

For posterior bleeds, more aggressive management is often required, including posterior nasal packing (e.g., Foley catheter), arterial ligation (sphenopalatine, ethmoidal arteries), or embolization via interventional radiology. Tranexamic acid, an antifibrinolytic agent, has shown promise in reducing epistaxis severity and duration, particularly in patients with recurrent bleeds or those on anticoagulants.

While most nosebleeds are self-limiting and benign, approximately 10% are considered serious. Fatalities are exceedingly rare, underscoring the generally favorable prognosis. Prevention strategies focus on maintaining nasal mucosal hydration through saline sprays, humidifiers, and topical emollients like petroleum jelly.

Educating patients on avoiding nose picking and managing underlying conditions like hypertension and allergies is crucial. The incidence of epistaxis peaks in two age groups: children under 10 and adults over 50, suggesting age-related changes in nasal vasculature and mucosal integrity. As the population ages and the use of anticoagulants and antiplatelet agents increases, understanding and effectively managing epistaxis remains a vital clinical skill, with ongoing research exploring novel hemostatic agents and minimally invasive surgical techniques.